Authors:
Hromadnikova, I
Sedlacek, P
Stary, J
Cermakova, M
Vavrinec, J
Stechova, K
Dolezalova, L
Sviland, L
Dickinson, AM
Citation: I. Hromadnikova et al., An in vitro skin explant assay as a predictive assay for graft-versus-hostdisease in a cohort of pediatric transplants, PEDIAT TRAN, 5(4), 2001, pp. 258-265
Authors:
Sviland, L
Hromadnikova, I
Sedlacek, P
Cermakova, M
Stechova, K
Holler, E
Eissner, G
Schulz, U
Kolb, HJ
Jackson, G
Wang, XN
Dickinson, AM
Citation: L. Sviland et al., Histological correlation between different centers using the skin explant model to predict graft-versus-host disease following bone marrow transplantation, HUMAN IMMUN, 62(11), 2001, pp. 1277-1281
Authors:
Krskova-Honzatkova, L
Cermak, J
Sajdova, J
Stary, J
Sedlacek, P
Sieglova, Z
Citation: L. Krskova-honzatkova et al., Loss of heterozygosity and heterogeneity of its appearance and persisting in the course of acute myeloid leukemia and myelodysplastic syndromes, LEUK RES, 25(1), 2001, pp. 45-53
Authors:
Sedlacek, P
Stary, J
Vodvarkova, S
Polouckova, A
Gasova, Z
Marinov, I
Formankova, R
Citation: P. Sedlacek et al., Hematopoietic stem cell transplantation in children with hematological malignancies across HLA barriers - reasonable alternative?, NEOPLASMA, 48(4), 2001, pp. 302-306
Authors:
Sedlacek, P
Trka, J
Zuna, J
Hrusak, O
Honzatkova-Krskova, L
Stary, J
Citation: P. Sedlacek et al., Monitoring of minimal residual disease and mixed chimerism in a case of high-risk TEL/AML1-positive acute lymphocytic leukemia, HAEMATOLOG, 85(10), 2000, pp. 1100-1102
Authors:
Formankova, R
Honzatkova, L
Sieglova, Z
Stary, J
Sedlacek, P
Brdicka, R
Citation: R. Formankova et al., Detailed monitoring of hematopoietic chimerism in a child treated by adoptive immunotherapy for high risk of relapse after BMT for acute myeloid leukemia, BONE MAR TR, 25(4), 2000, pp. 453-456
Authors:
Dickinson, AM
Hromadnikova, I
Sviland, L
Jackson, GH
Taylor, PRA
Vavrinec, J
Sedlacek, P
Cermakova, M
Stary, J
Vitek, A
Sajdova, J
Proctor, SJ
Citation: Am. Dickinson et al., Use of a skin explant model for predicting GVHD in HLA-matched bone marrowtransplants - effect of GVHD prophylaxis, BONE MAR TR, 24(8), 1999, pp. 857-863